| Metric | Value ($ M) | Q2 FY26 | Q3 FY25 |
|---|---|---|---|
| Revenue | 65.13 | 7.2% | 3.6% |
| Total Income | 65.13 | 7.2% | 3.6% |
| Expenditure | 57.15 | 2.0% | 0.2% |
| PBT | 4.60 | 130.0% | 307.2% |
| Net Profit | 3.63 | 46.4% | 316.1% |
| OPM | 12.24% | 4.47pp | 3.05pp |
| NPM | 5.57% | 1.50pp | 8.24pp |
| EPS | 0.66 | 46.7% | 312.9% |
Mesa Laboratories Reports Results for Nine Months Ended December 31, 2025
04 May 2026 · 4 May, 1:33 am
Summary
Mesa Laboratories, Inc. issued a press release on February 3, 2026, pertaining to its financial results for the three and nine months ended December 31, 2025. The press release is furnished as an exhibit to the 8-K filing.
Key Highlights
- 1
Mesa Laboratories issued a press release relating to its results for the three and nine months ended December 31, 2025.
- 2
The press release was issued on February 3, 2026.
Informational and educational content only. Not investment advice.